RNA
RNA
NASDAQ · Biotechnology

Avidity Biosciences Inc

$12.81
-0.13 (-1.00%)
As of Jun 23, 9:45 PM ET ·
Financial Highlights (FY 2026)
Revenue
18.61M
Net Income
-49,476,359
Gross Margin
Profit Margin
-265.9%
Rev Growth
+58.4%
D/E Ratio
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 39.7% 39.7%
Operating Margin -266.6% -239.9% -24.8% -24.2%
Profit Margin -265.9% -252.6% -27.6% -21.2%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 18.61M 11.75M 2.36B 2.44B
Gross Profit 936.04M 969.30M
Operating Income -49,608,480 -28,179,520 -583,930,228 -590,749,120
Net Income -49,476,359 -28,104,470 -651,372,475 -517,686,100
Gross Margin 39.7% 39.7%
Operating Margin -266.6% -239.9% -24.8% -24.2%
Profit Margin -265.9% -252.6% -27.6% -21.2%
Rev Growth +58.4% +58.4% +6.9% +24.6%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 0 0 2.58B 3.15B
Total Equity 5.59B 5.69B
D/E Ratio 0.46 0.55
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -49,283,065 -29,549,931 -865,943,607 -944,563,645
Free Cash Flow -400,975,764 -475,814,962